Clinical Trials Directory

Trials / Completed

CompletedNCT00372931

A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
120 (planned)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Conditions

Interventions

TypeNameDescription
DRUGAL-37807

Timeline

Start date
2006-05-01
Primary completion
2007-08-01
First posted
2006-09-07
Last updated
2008-04-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00372931. Inclusion in this directory is not an endorsement.

A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00372931) · Clinical Trials Directory